BILLERICA, Mass., Jan. 3, 2017 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 35th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Tony Mattacchione, Senior Vice President and CFO will present on behalf of the company on Monday, January 9th, 2017 at 8:00 AM Pacific Time.
A live audio webcast of the presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: http://www.bruker.com.
Head of Investor Relations
T: +1 (978) 663 – 3660, ext. 1479
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-35th-annual-jp-morgan-healthcare-conference-300384750.html
SOURCE Bruker Corporation